oral SGLT2 inhibitor

Clinical candidate for diabetes

from literature SGLT2 inhibitor

Bioorganic Med. Chem. Lett.

GC Pharma (Green Cross)

oral SGLT2 inhibitor - GC Pharma (Green Cross)

Context. GCC5694A (GC Pharma (Green Cross)) is an oral SGLT2 inhibitor. SGLT2 inhibitors help glycemic control in diabetes by preventing reabsorption of glucose in the kidney. Dapagliflozin was the…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: